AGL 40.22 Increased By ▲ 0.21 (0.52%)
AIRLINK 127.00 Decreased By ▼ -0.99 (-0.77%)
BOP 6.61 Increased By ▲ 0.01 (0.15%)
CNERGY 4.50 Decreased By ▼ -0.10 (-2.17%)
DCL 8.65 Increased By ▲ 0.17 (2%)
DFML 41.73 Increased By ▲ 0.25 (0.6%)
DGKC 87.15 Increased By ▲ 0.57 (0.66%)
FCCL 32.40 Increased By ▲ 0.26 (0.81%)
FFBL 65.40 Decreased By ▼ -0.02 (-0.03%)
FFL 10.22 Decreased By ▼ -0.03 (-0.29%)
HUBC 109.88 Decreased By ▼ -0.61 (-0.55%)
HUMNL 14.60 Decreased By ▼ -0.15 (-1.02%)
KEL 5.12 Decreased By ▼ -0.01 (-0.19%)
KOSM 7.72 Increased By ▲ 0.60 (8.43%)
MLCF 41.65 No Change ▼ 0.00 (0%)
NBP 59.60 Decreased By ▼ -0.49 (-0.82%)
OGDC 194.50 Decreased By ▼ -0.19 (-0.1%)
PAEL 28.27 Increased By ▲ 0.32 (1.14%)
PIBTL 7.87 Decreased By ▼ -0.13 (-1.63%)
PPL 152.34 Increased By ▲ 1.17 (0.77%)
PRL 26.60 Decreased By ▼ -0.28 (-1.04%)
PTC 16.05 Increased By ▲ 0.05 (0.31%)
SEARL 81.75 Increased By ▲ 3.55 (4.54%)
TELE 7.49 Increased By ▲ 0.10 (1.35%)
TOMCL 35.49 Decreased By ▼ -0.18 (-0.5%)
TPLP 8.25 Increased By ▲ 0.34 (4.3%)
TREET 16.18 Increased By ▲ 0.29 (1.83%)
TRG 52.73 Decreased By ▼ -0.03 (-0.06%)
UNITY 26.60 Increased By ▲ 0.05 (0.19%)
WTL 1.26 Decreased By ▼ -0.01 (-0.79%)
BR100 9,913 Decreased By -6.9 (-0.07%)
BR30 30,779 Increased By 27.7 (0.09%)
KSE100 93,468 Increased By 243.4 (0.26%)
KSE30 28,952 Increased By 67.1 (0.23%)

imageMUMBAI: India's Ranbaxy Laboratories Ltd fell 4.4 percent in pre-open trading on Friday after the US Food and Drug Administration (FDA) revoked tentative approval for certain generic drugs.

The FDA revoked permission for Ranbaxy's cheap copy of AstraZeneca Plc's heartburn drug Nexium and for a copy of Roche Holding AG's antiviral Valcyte after the Indian drug maker's plants were banned over quality control issues.

Copyright Reuters, 2014

Comments

Comments are closed.